Accrued Expenses & Other Current Liabilities

12 Months Ended

Dec. 31, 2019

Payables and Accruals [Abstract]

Accrued Expenses & Other Current Liabilities

Accrued Expenses & Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	DECEMBER 31,
(in thousands)	2019		2018
Accrued expenses and other current liabilities:
Accrued compensation and benefits	$	11,169	$	10,438
Accrued consulting and professional fees	3,810		3,927
Accrued research and development (1)	8,734		7,503
Accrued revenue reserves(2)	38,450		10,155
Accrued other(3)	3,213		6,358
Total accrued expenses and other current liabilities	$	65,376	$	38,381

 

(1) Comprised primarily of accruals related to fees for investigative sites, contract research organizations, contract manufacturing organizations and other service providers that assist in conducting preclinical research studies and clinical trials. Also included are liabilities incurred related to the Avizorex acquisition.

(2) Comprised primarily of accruals related to commercial and government rebates as well as returns.

(3)

Comprised primarily of accruals related to accrued interest as well as other business-related expenses.